JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luchi, R. J.
Right arrow Articles by Kritcher, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luchi, R. J.
Right arrow Articles by Kritcher, E. M.
Journal of Pharmacology And Experimental Therapeutics, Vol. 158, Issue 3, 540-545, 1967
Copyright © 1967 by American Society for Pharmacology and Experimental Therapeutics


DRUG EFFECTS ON CARDIAC MYOSIN ADENOSINE TRIPHOSPHATASE ACTIVITY

Robert J. Luchi 1 and Eve Marie Kritcher 1

1 Department of Medicie, Robinette Foundation, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania

Various agents known to alter cardiac contractility were examined for their effect on dog cardiac myosin adenosine triphosphatase (ATPase) activity. Anesthetic agents were shown to have either the same, or no effect, on cardiac myosin ATPase activity which persisted through the extraction and purification phase. No stimulatory or depressant effect on enzyme activity was observed when quinidine, procaine amide, angiotensin, digitoxin, digoxin, ouabain or inotropic sympathomimetic amines were incubated with normal cardiac myosin. Myosin obtained from dogs with "spontaneously" occurring congestive heart failure also exhibited no change in enzyme activity in the presence of digoxin or the inotropic sympathomimetic amines. Calcium and magnesium ions, however, had an effect on cardiac myosin ATPase activity which correlated with their in vivo action on cardiac contractility. The effect of magnesium and calcium on myosin enzyme activity was studied further. The association constant between calcium and myosin is 1.8 x 104 with eight binding sites on the myosin molecule for calcium. Calcium activation of myosin ATPase activity appears to relate to the formation of calcium-ATP rather than to a direct effect of calcium on the myosin enzyme site. The inhibitory effect of magnesium on calcium-activated myosin ATPase activity could not be related to reduced calcium-ATP formation or to a direct effect of magnesium on the myosin molecule.

Submitted on May 4, 1967
Accepted on August 9, 1967







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics.